CS Diagnostics Corp. (CSDX)
OTCMKTS · Delayed Price · Currency is USD
0.2250
-0.0240 (-9.64%)
Jan 20, 2026, 3:07 PM EST
CS Diagnostics Market Cap
CS Diagnostics has a market cap or net worth of $56.25 million as of January 20, 2026. Its market cap has decreased by -85.06% in one year.
Market Cap
56.25M
Enterprise Value
56.25M
Revenue
98.73K
Ranking
n/a
PE Ratio
2,900.29
Stock Price
$0.23
Market Cap Chart
Since March 31, 2016, CS Diagnostics's market cap has increased from 738.94K to 56.25M, an increase of 7,512.06%. That is a compound annual growth rate of 55.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 62.25M | -18.60% |
| Dec 31, 2025 | 76.47M | -49.21% |
| Dec 31, 2024 | 150.56M | 38,005.96% |
| Dec 29, 2023 | 395.10K | -47.85% |
| Dec 23, 2022 | 757.61K | 5,499.87% |
| Dec 31, 2021 | 13.53K | -98.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |